Professor Kaufman was an exceptional Israeli oncologist, globally respected for her pioneering work in the field of breast cancer research and, more specifically, BRCA mutations and genetics. She has been an investigator on many important clinical trials, some of which are essential to the development of PARP inhibitors for the treatment of BRCA-related cancers.